Progress in understanding and treating multiple sclerosis evolves continuously and not always on a schedule aligned with scientific meeting deadlines. This session, near the end of the 2021 CMSC Annual Meeting, will address three topics of common interest to the MS care provider team. The session is recommended for all disciplines involved in MS care and will cover the latest information on the prevalence of MS by race in the US, an update on the latest research into candidates for biomarkers in MS, and data collected in the CoViMS registry related to MS management during the current SARSCoV-2 pandemic. All are invited to attend these important discussions, as we head back to our respective roles in the care and treatment of MS.
[learn_press_profile]